CEPI and Gavi commit over $100 million to develop a vaccine for the Bundibugyo Ebola strain driving the DRC outbreak.
An Ebola outbreak caused by the Bundibugyo strain is spreading in the Democratic Republic of Congo and Uganda. Existing vaccines target the Zaire strain and are not expected to work against Bundibugyo. CEPI and Gavi have committed roughly $102 million to fast-track vaccine candidates from IAVI, Oxford, and Moderna.
13
Divergence score
3 outlets covered it, splitting into 3 framing camps across 3 bias groups.
3 camps
3 bias groups
Market signalBETA
The spectrum · how 3 outlets placed this story
LeftCenterRight
NPR
Jerusalem Post
Bloomberg
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
The split, in one line
Coverage splits between vaccine development urgency (Jerusalem Post, Bloomberg) and institutional capacity gaps (NPR, Bloomberg), with Bloomberg uniquely emphasizing crisis in containment systems amid U.S. WHO withdrawal.
How each outlet covered it
Lightly covered so far
Too few outlets to map a left-right split. Here is each take as it stands.
Sparse coverage · 3 outlets
“Scientists race to develop Ebola vaccine amid DRC outbreak”
“Ebola Bundibugyo Strain Spreads Fast”
“What will it take to get a vaccine for the Ebola strain driving the current outbreak?”
Tracked claims from across the political spectrum
Fact ledger
Corroborated
Disputed